Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Breast Cancer Research and Treatment|June 21, 2018
Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp coolingM Martín, J C de la Torre-Montero, S López-Tarruella, et al.Breast Cancer Research and Treatment|July 17, 2018
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp coolingM Martín, J C de la Torre-Montero, S López-Tarruella, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Current controversies in the management of breast cancerI Tusquets, L García-Estévez, E Adrover, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.European Journal of Cancer (Oxford, England : 1990)|March 25, 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-studyJ L Ethier, A Ocaña, A Rodríguez Lescure, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2016
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)A González, A Lluch, E Aba, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 17, 2018
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudyA J Templeton, Á Rodríguez-Lescure, A Ruíz, et al.ESMO Open|May 14, 2021
Ten-year assessment of a cancer fast-track programme to connect primary care with oncology: reducing time from initial symptoms to diagnosis and treatment initiationM T Martínez, J Montón-Bueno, S Simon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimenM Martín, A Lluch, M A Seguí, et al.Pageof 18